Your browser doesn't support javascript.
loading
Vagus Nerve Stimulation Paired With Rehabilitation for Upper Limb Motor Impairment and Function After Chronic Ischemic Stroke: Subgroup Analysis of the Randomized, Blinded, Pivotal, VNS-REHAB Device Trial.
Dawson, Jesse; Engineer, Navzer D; Cramer, Steven C; Wolf, Steven L; Ali, Rushna; O'Dell, Michael W; Pierce, David; Prudente, Cecília N; Redgrave, Jessica; Feng, Wuwei; Liu, Charles Y; Francisco, Gerard E; Brown, Benjamin L; Dixit, Anand; Alexander, Jen; DeMark, Louis; Krishna, Vibor; Kautz, Steven A; Majid, Arshad; Tarver, Brent; Turner, Duncan L; Kimberley, Teresa J.
Afiliação
  • Dawson J; School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • Engineer ND; MicroTransponder Inc., Austin, TX, USA.
  • Cramer SC; Department of Neurology, David Geffen School of Medicine at UCLA, and California Rehabilitation Institute; Los Angeles, CA, USA.
  • Wolf SL; Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of Medicine, Atlanta, GA, USA.
  • Ali R; Department of Neurosciences, Spectrum Health, Grands Rapids, MI, USA.
  • O'Dell MW; Clinical Rehabilitation Medicine, Weill Cornell Medicine, New York City, NY, USA.
  • Pierce D; MicroTransponder Inc., Austin, TX, USA.
  • Prudente CN; MicroTransponder Inc., Austin, TX, USA.
  • Redgrave J; Sheffield Institute for Neurological Sciences (SITraN), Sheffield, UK.
  • Feng W; Department of Neurology, Duke University School of Medicine, Durham, NC, USA.
  • Liu CY; USC Neurorestoration Center and Department of Neurological Surgery, USC Keck School of Medicine, Los Angeles, CA, USA, and Rancho Los Amigos National Rehabilitation Center, Downey, CA, USA.
  • Francisco GE; Department of Physical Medicine and Rehabilitation, The University of Texas Health Science Center McGovern Medical School, and The Institute for Rehabilitation and Research (TIRR) Memorial Hermann Hospital; Houston, TX, USA.
  • Brown BL; Department of Neurosurgery, Ochsner Neuroscience Institute, Covington, Los Angeles, USA.
  • Dixit A; Stroke Service, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Alexander J; School of Cardiovascular and Metabolic Health, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
  • DeMark L; Brooks Rehabilitation, Jacksonville, FL, USA.
  • Krishna V; Department of Neurosurgery, University of North Carolina, Chapel Hill, NC, USA.
  • Kautz SA; Ralph H. Johnson VA Medical Center, Charleston, SC, USA and Department of Health Sciences and Research, Medical University of South Carolina, Charleston, SC, USA.
  • Majid A; Sheffield Institute for Neurological Sciences (SITraN) and Sheffield Teaching Hospitals, Sheffield, UK.
  • Tarver B; MicroTransponder Inc., Austin, TX, USA.
  • Turner DL; School of Health, Sport and Bioscience, University of East London, London, UK.
  • Kimberley TJ; Department of Physical Therapy, MGH Institute of Health Professions, Boston, MA, USA.
Neurorehabil Neural Repair ; 37(6): 367-373, 2023 Jun.
Article em En | MEDLINE | ID: mdl-36226541
ABSTRACT

BACKGROUND:

Vagus Nerve Stimulation (VNS) paired with rehabilitation improved upper extremity impairment and function in a recent pivotal, randomized, triple-blind, sham-controlled trial in people with chronic arm weakness after stroke.

OBJECTIVE:

We aimed to determine whether treatment effects varied across candidate subgroups, such as younger age or less injury.

METHODS:

Participants were randomized to receive rehabilitation paired with active VNS or rehabilitation paired with sham stimulation (Control). The primary outcome was the change in impairment measured by the Fugl-Meyer Assessment Upper Extremity (FMA-UE) score on the first day after completion of 6-weeks in-clinic therapy. We explored the effect of VNS treatment by sex, age (≥62 years), time from stroke (>2 years), severity (baseline FMA-UE score >34), paretic side of body, country of enrollment (USA vs UK) and presence of cortical involvement of the index infarction. We assessed whether there was any interaction with treatment.

FINDINGS:

The primary outcome increased by 5.0 points (SD 4.4) in the VNS group and by 2.4 points (SD 3.8) in the Control group (P = .001, between group difference 2.6, 95% CI 1.03-4.2). The between group difference was similar across all subgroups and there were no significant treatment interactions. There was no important difference in rates of adverse events across subgroups.

CONCLUSION:

The response was similar across subgroups examined. The findings suggest that the effects of paired VNS observed in the VNS-REHAB trial are likely to be consistent in wide range of stroke survivors with moderate to severe upper extremity impairment.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Estimulação do Nervo Vago / Transtornos Motores / Reabilitação do Acidente Vascular Cerebral / AVC Isquêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Estimulação do Nervo Vago / Transtornos Motores / Reabilitação do Acidente Vascular Cerebral / AVC Isquêmico Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido